Publications and Presentations Database
P
LaRusse, S., Katzen, H., Brown, T., Barber, M., Whitehouse, P. J., Green, R. C., et al.
(2002).
Participant recall of their own apolipoprotein E (APOE) genotype and risk estimate after six weeks: Results from the REVEAL Study.
I
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Fasaye, G., Obisean, T., Cupples, L. A., et al.
(2007).
Incorporating Ethnicity into Genetic Risk Assessment for Alzheimer's Disease: The REVEAL Study Experience.
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Cupples, L. A., Whitehouse, P. J., Relkin, N. R., et al.
(2008).
The Impact of an Education and Risk Evaluation Protocol on Perceived Benefits, Risks and Limitations of Genetic Susceptibility Testing for Alzheimer's Disease.
H
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al.
(2002).
How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
] 